The market for medical-professional liability insurance has tightened in ways that change which med-mal files are worth opening. Three years after AB 35 rewrote California's MICRA caps and after a decade of carrier roll-ups concentrated the writing, plaintiff firms screening hospital and physician-defendant cases face a different set of economic and tactical questions than the ones their intake forms were built around.
The shift is not abstract. NORCAL Mutual's 2021 absorption into ProAssurance removed one of California's three legacy mutuals, leaving The Doctors Company and a small group of national writers as the carriers most plaintiff counsel will see across the table. At the same time, hospital employment and private-equity acquisition have changed who actually pays when a physician makes a mistake — and who can be sued for it.
The carrier picture after a decade of roll-ups
For most of the late 1990s and 2000s, California physicians bought from a small group of mutuals — The Doctors Company, NORCAL, and SCPIE before it was sold to TDC in 2008. ProAssurance's acquisition of NORCAL closed in May 2021 for around $450 million. What remains is a market where TDC writes the largest share of California physician business, ProAssurance picks up much of the rest of the mutual book, and national carriers like MedPro Group, Coverys, and MagMutual round out the field.
For plaintiff intake, this matters in two practical ways. Claims handling is more centralized — adjusters and panel counsel are picked from smaller in-house rosters, and the cost-of-defense tolerance at each carrier is more predictable than it used to be. Settlement authority sits with fewer claims committees. If you have worked against a TDC panel firm once, you have a reasonable read on how the next case from that panel will be staffed and posted.
The other consequence is reserves. Consolidated carriers post fewer but larger reserves and are more willing to push borderline cases to trial when an adverse verdict at the post-AB 35 cap is still a manageable loss against their book. A non-economic verdict at the 2026 statutory ceiling — somewhere in the mid-$400,000s for non-death cases — does not move the needle for a carrier writing several billion in annual premium.
Physician practice changes and who actually holds the policy
The other half of the picture is on the physician side. Hospital employment of physicians has been creeping up nationally; in California, the corporate practice of medicine prohibition rooted in Business and Professions Code §2400 limits direct hospital employment outside of specific exceptions (district hospitals, teaching institutions, qualifying medical foundations). The workaround has been management services organizations and friendly-PC structures that let a non-physician entity own the practice infrastructure while a physician-owned professional corporation employs the clinicians.
Private equity has accelerated this. Optum's continued buying of physician groups, KKR's emergency-medicine investments, and a long list of mid-market PE deals in dermatology, ophthalmology, anesthesia, and orthopedic surgery have moved tens of thousands of California physicians from independent or small-group practice into corporate-owned platforms. From a plaintiff perspective, this changes the coverage and defendant analysis in three ways.
First, the policy in play is often the platform's commercial program rather than the individual physician's mutual policy. Limits are higher, but the appetite for early defense investment is also higher. Second, vicarious-liability theories against the platform entity become available when the physician is an employee or a tightly controlled contractor — and the ostensible-agency doctrine remains good law in California for hospital-based specialists the patient never chose. Third, the indemnity tail on practice acquisitions sometimes leaves a gap that surfaces months into litigation when prior-acts coverage was not properly written into the deal.
Case selection in a consolidated market
Two screening questions matter more than they did five years ago. Who insures the defendant, and who employs the defendant?
Carrier identification at intake is more useful when there are only a handful of meaningful writers. A subpoena to the Medical Board, a billing record showing the group NPI, or even the practice website's legal notices will usually identify the carrier within a few hours. Once identified, the carrier's reserving and settlement posture is a known quantity. TDC files behave differently from ProAssurance files, and both behave differently from a self-insured retention layer sitting under a hospital system's captive.
Employment status drives the defendant list. An independently contracted radiologist reading at a community hospital is a different case than an employed hospitalist working under a friendly-PC structure owned by a PE platform. The first one is a single-policy case with limited vicarious exposure. The second one opens up the platform, the management company, and — depending on the agency facts — the hospital itself.
These distinctions matter for the same reason they matter in rideshare non-delegable-duty work: corporate structure dictates the defendant tree, and the defendant tree dictates the recovery ceiling.
The AB 35 numbers and what they do to fee math
AB 35 took effect January 1, 2023. Non-death non-economic damages were capped at $350,000 in 2023, rising in equal annual increments to $750,000 by 2033. Wrongful-death non-economic damages were capped at $500,000 in 2023, rising to $1,000,000 by 2033. After 2033, a 2% annual inflation adjustment applies. The pre-2023 single $250,000 cap was replaced with separate caps that can each be reached when both a provider and an institutional defendant are independently at fault.
For a case tried in 2026, the operative non-economic ceilings are in the mid-$400,000s for non-death cases and the mid-$600,000s for wrongful death, and a case with both a provider defendant and a separately liable institutional defendant can recover under two caps. The Business and Professions Code §6146 fee schedule was also rewritten — the sliding scale is more generous to plaintiff counsel than the pre-2023 version, and a contingent fee on the full recovery (including the higher caps) produces meaningfully better economics on the cases that reach verdict or settlement.
The practical result: cases that did not pencil out under the pre-AB 35 single cap are starting to. A clean liability case with $300,000 in past medicals, modest future-care needs, and a sympathetic plaintiff was a referral-out file in 2019. With two available caps and a better fee schedule, the same fact pattern can support full-scale litigation costs and a viable contingent fee.
Corporate practice of medicine and the institutional defendant
The CPM doctrine is the structural reason California hospital-employed-physician cases look different here than in Texas or Florida. Hospitals cannot directly employ physicians except through specific statutory carve-outs, so what looks like an employer-employee relationship is often a contractual one routed through a medical foundation, an MSO, or a friendly PC.
For plaintiff pleading purposes, the working approach is to allege the actual relationship — ostensible agency, joint venture, or the relevant statutory employment exception — rather than rely on a generic respondeat-superior theory. Discovery into the management services agreement, the income-distribution arrangement, and the physician's actual day-to-day control will usually establish either real or ostensible agency at the hospital level. The same discovery establishes the PE platform's role when the defendant physician's employer is a foundation owned by a national investor group.
This is where the recent appellate work on agency and non-delegable duty in the rideshare and trucking contexts is portable. The arguments that survived demurrer in the cases summarized in our June wrap on the California PI referral-ban initiative and the $49M trucking verdict translate into med-mal pleading against PE-controlled platforms.
Practical screening adjustments
Three intake changes are working for firms that have adapted.
First, capture the employer chain at the first interview. The physician's individual NPI, the group billing NPI, the entity that issued the appointment letter, and the entity listed on the patient-facing signage are often four different names. Pull all four before declining or accepting the file.
Second, run a coverage check on the platform before declining. A case that looks marginal against a single physician's $1M per-claim policy looks different against a PE-owned dermatology platform with a $25M commercial program and an excess tower above it.
Third, calendar the §364 notice and §340.5 limitations period at intake. Carrier consolidation has not changed the procedural traps — a missed 90-day notice of intent or a mis-calculated one-year-from-discovery still kills cases, and the consolidated carriers are well-staffed to plead the defense at the first opportunity. The same procedural discipline that protects you in the tort-reform and damages-cap fights covered in our June 4 PI Week update on New York and Virginia tort changes protects you here.
The carrier and practice changes do not make med-mal easier. They make it different. The cases worth opening in 2026 look less like the solo-physician files of the 1990s and more like the layered corporate-defendant work plaintiff PI firms already do in trucking and rideshare — with concentrated carriers, layered coverage, and structural pleading questions that need to be answered before the file is taken, not after.